Factory Wholesale Tirzepatide 10mg 15mg 30mg 40mg 60mg Sterile CAS 2023788-19-2
Product Description:Tirzepatide powder is the raw pharmaceutical material of Tirzepatide, a synthetic dual agonist of the GLP-1 (glucagon-like peptide-1) receptor and GIP (glucose-dependent insulinotropic polypeptide) receptor. This innovative compound is primarily used for the treatment of type 2 diabetes, helping to regulate blood glucose levels by stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Additionally, Tirzepatide has shown
Tirzepatide 30mg
,Tirzepatide 10mg
,Tirzepatide 15mg
Product Description:
Tirzepatide powder is the raw pharmaceutical material of Tirzepatide, a synthetic dual agonist of the GLP-1 (glucagon-like peptide-1) receptor and GIP (glucose-dependent insulinotropic polypeptide) receptor. This innovative compound is primarily used for the treatment of type 2 diabetes, helping to regulate blood glucose levels by stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Additionally, Tirzepatide has shown potential for weight loss, making it a promising candidate for obesity treatment. In powder form, Tirzepatide is typically used in the pharmaceutical manufacturing process, where it undergoes further formulation into injectable medications. Its mechanism of action, targeting both GLP-1 and GIP receptors, sets it apart from other diabetes treatments, providing enhanced metabolic control.
Technical Parameters:
| Products Name: | Tirzepatide |
| CAS No.: | 2023788-19-2 |
| Purity: | ≥99.5% |
| Appearance: | White Lyophilized powder |
| Logo printing: | Available |
| Storage: | Cool Dry Place |
Dosage:
The dosage of Tirzepatide for treating type 2 diabetes, typically follows a gradual titration to minimize side effects and optimize effectiveness. It is administered via subcutaneous injection once weekly.
Here’s a general dosing schedule:
1. Starting dose: 2.5 mg once a week for the first 4 weeks. This low dose helps the body adjust to the medication.
2. Dose escalation:
After 4 weeks at 2.5 mg, the dose is increased to 5 mg once weekly.
If further blood sugar control is needed, the dose may be increased in 2.5 mg increments every 4 weeks, up to a maximum dose of 15 mg per week.
Titration schedule:
Week 1–4: 2.5 mg weekly
Week 5–8: 5 mg weekly
After 8 weeks: Based on effectiveness and tolerance, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or 15 mg.
The dosage is tailored to the individual patient’s needs and response to the medication. Higher doses may offer additional benefits for glucose control and weight loss, but they also increase the likelihood of gastrointestinal side effects, such as nausea or diarrhea.
Patients should follow the dosage prescribed by their healthcare provider to ensure safety and efficacy.
Function:
1. Blood Sugar Regulation:
Tirzepatide acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. By stimulating these receptors, it enhances insulin secretion from the pancreas in response to elevated blood glucose levels, thereby helping to lower and stabilize blood sugar levels.
2. Glucagon Suppression:
It reduces the secretion of glucagon, a hormone that raises blood sugar levels. This effect helps to prevent hyperglycemia (high blood sugar) and contributes to overall glucose control.
3. Slowing Gastric Emptying:
Tirzepatide slows down gastric emptying, which helps regulate the rate at which glucose is released into the bloodstream after meals. This contributes to smoother postprandial (after eating) blood sugar levels and enhances feelings of fullness.
4. Weight Loss:
One of the notable benefits of Tirzepatide is its ability to promote significant weight loss. By reducing appetite and increasing satiety, it encourages lower food intake, which can be particularly beneficial for individuals with type 2 diabetes who may also be struggling with obesity.
Packing and Shipping:
FAQ:
1.Can I get samples for testing?
Yes, sample can be provided, but you will need to pay the freight.
2.What's the delivery leadtime?
3-7 days by air after payment, if it is by sea, the shipment time should be determined according to the shipping date.
3. What is the shelf life for the products?
Most products shelf life 24-36 months.
4. What's your delivery time?
Usually, shipment will be made within 1-3 days against confirmed order.
5. How about the validity of the offer?
Usually, our offer is valid for 2 week. However, validity might vary between different products.
-
99% Purity High Quality 5mg 10mg 15mg In Stock Safe Shipping Tirzepatide
Product Description: Tirzepatide powder is the active pharmaceutical ingredient of Tirzepatide, a novel synthetic peptide designed for the treatment of type 2 diabetes and potentially for obesity management. As a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, Tirzepatide enhances the body’s natural insulin response, decreases glucagon secretion, and slows gastric emptying. These actions work synergisticall
-
Factory Direct Weight Loss Ozempic Semaglutide Tirzepatide 5mg-15mg
Product Description: Tirzepatide powder is the raw form of Tirzepatide, a synthetic peptide used primarily in the treatment of type 2 diabetes. It acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, enhancing insulin secretion and lowering blood sugar levels. Tirzepatide also slows gastric emptying and promotes weight loss, making it a valuable option for patients with diabetes and obesity. Typically
-
Factory Supply Semaglutide Tirzepatide CAS 2023788-19-2 with Fast Shipping to UK, USA, Europe
Product Description: Tirzepatide powder is the raw form of Tirzepatide, a groundbreaking synthetic peptide used primarily for managing type 2 diabetes. This compound is a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, which play a critical role in glucose metabolism. By activating both receptors, Tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses the release of
